NF-kB comprises an important group of transcription factors, found in virtually all mammalian cell types, that regulate numerous genes containing specific """"""""kB"""""""" sites. These include at least two proto-oncogenes (MYC and MYB) and genes encoding cytokines, immunoreceptors, and adhesion molecules. A broad variety of agents, including mitogens, cytokines, and environmental stresses, induce NF-kB activity. It has a key role in immune responses and is required for proliferation of B- and T-lymphocytes in response to most mitogenic signals. """"""""IkB"""""""" proteins inhibit NF-kB by sequestering it in the cytoplasm or by inhibiting its DNA-binding activity. They identified an atypical member of the IkB family, encoded by the BCL3 gene, through its involvement in a 14;19 translocation found in some patients with chronic lymphocytic leukemia (CLL). Like other IkBs, it binds to certain NF-kB factors, but, rather than inhibiting, it activates transcription through two distinct mechanisms. It can act either as an antirepressor or as a coactivator; in the latter case, it forms a ternary complex with DNA and NF-kB in which transactivation domains on BCL3 stimulate transcription. The proposed work centers on the hypothesis that BCL3 provides an alternative mode of transcriptional activation of critical kB-regulated genes. To test the hypothesis that overexpression of BCL3 aberrantly activates kB-dependent genes and thereby contributes to leukemogenesis, they generated five lines of transgenic mice that overexpress BCL3 in their lymphocytes. They will determine whether the mice develop overt neoplasia or expansion of the B-cell population or have other lymphocytic abnormalities, including altered expression of genes regulated by NF-kB. So far, they have found frequent lymphadenopathy and a consistent increase in the fraction of lymph node B-cells. They will test three additional, mechanistic hypotheses based on the results so far: 1) that BCL3 binding influences the DNA-sequence specificity of NF-kB proteins; 2) that protein-protein interactions influence BCL3's ability to form ternary complexes with NF-kB proteins and DNA; and 3) that phosphorylation enhances its ability to function as a coactivator, but decreases its antirepressor activity. NF-kB proteins regulate a remarkably wide variety of genes that direct key biological processes. Their involvement in so many pathways raises the question of how specificity is conferred. They propose that BCL3, as the only IkB protein known to activate transcription, has a particularly important role in selective activation of a subset of critical kB-regulated genes. The proposed experiments are all directed at testing this hypothesis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
7R01CA055356-08
Application #
6153449
Study Section
Pathology B Study Section (PTHB)
Program Officer
Shen, Grace L
Project Start
1991-07-01
Project End
2000-11-30
Budget Start
1999-04-01
Budget End
2000-11-30
Support Year
8
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Nebraska Medical Center
Department
Pathology
Type
Schools of Medicine
DUNS #
City
Omaha
State
NE
Country
United States
Zip Code
68198
Ge, Baosheng; Li, Olga; Wilder, Phillip et al. (2003) NF-kappa B regulates BCL3 transcription in T lymphocytes through an intronic enhancer. J Immunol 171:4210-8
Baron, Beverly W; Anastasi, John; Thirman, Michael J et al. (2002) The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis. Proc Natl Acad Sci U S A 99:2860-5
Giver, C R; Moore 2nd, D H; Pallavicini, M G (2000) Radiation-induced translocations in mice: persistence, chromosome specificity, and influence of genetic background. Radiat Res 154:283-92
Ong, S T; Hackbarth, M L; Degenstein, L C et al. (1998) Lymphadenopathy, splenomegaly, and altered immunoglobulin production in BCL3 transgenic mice. Oncogene 16:2333-43
McKeithan, T W; Takimoto, G S; Ohno, H et al. (1997) BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies: a molecular and cytogenetic study. Genes Chromosomes Cancer 20:64-72
Sadhu, A; Shen, M L; Hackbarth, M et al. (1997) CpG-rich sequences close to the site of duplication within the human IGH constant region. Immunogenetics 45:365-70
Bundy, D L; McKeithan, T W (1997) Diverse effects of BCL3 phosphorylation on its modulation of NF-kappaB p52 homodimer binding to DNA. J Biol Chem 272:33132-9
Zhang, Q; Didonato, J A; Karin, M et al. (1994) BCL3 encodes a nuclear protein which can alter the subcellular location of NF-kappa B proteins. Mol Cell Biol 14:3915-26
Birn, D J; McKeithan, T W; Nucifora, G (1993) An EcoRI polymorphism in the AML1 gene. Hum Mol Genet 2:1084
Baron, B W; Billstrand, C; Madronero, L et al. (1993) HindIII polymorphism in the BCL6 gene. Hum Mol Genet 2:1513

Showing the most recent 10 out of 12 publications